These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2531949)
21. In vivo effects of cyclic administration of 15-deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis. Kälsch AI; Schmitt WH; Breedijk A; Marinaki S; Weigerding S; Nebe TC; Nemoto K; van der Woude FJ; Yard BA; Birck R Clin Exp Immunol; 2006 Dec; 146(3):455-62. PubMed ID: 17100765 [TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive mode of action of deoxyspergualin in mice, as compared with cyclosporine A and mizoribine. Okubo M; Masaki Y; Kamata K; Sato N; Inoue K; Umetani N Transplant Proc; 1989 Feb; 21(1 Pt 1):1085-7. PubMed ID: 2784882 [No Abstract] [Full Text] [Related]
23. Suppression of macrophage function and prolongation of graft survival by the new guanidinic-like structure, 15-deoxyspergualin. Dickneite G; Schorlemmer HU; Sedlacek HH; Falk W; Ulrichs K; Müller-Ruchholtz W Transplant Proc; 1987 Feb; 19(1 Pt 2):1301-4. PubMed ID: 3547862 [No Abstract] [Full Text] [Related]
24. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo. Yuh DD; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605 [No Abstract] [Full Text] [Related]
25. Effects of 15-deoxyspergualin on proliferative responses and cytokine gene expression in vitro. Imamura M; Zhu X; Hashino S; Han CW; Tanaka J; Kobayashi H; Imai K; Kasai M; Sakurada K; Miyazaki T Immunobiology; 1994 Dec; 192(1-2):24-39. PubMed ID: 7750988 [TBL] [Abstract][Full Text] [Related]
26. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. Vathsala A; Chou TC; Kahan BD Transplantation; 1990 Feb; 49(2):463-72. PubMed ID: 1689520 [TBL] [Abstract][Full Text] [Related]
27. [Study of immunosuppressive mechanism of deoxymethylspergualin in vitro]. Uemura T Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1301-7. PubMed ID: 8355445 [TBL] [Abstract][Full Text] [Related]
28. Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (+/-)-15-deoxyspergualin. Dickneite G; Schorlemmer HU; Sedlacek HH Int J Immunopharmacol; 1987; 9(5):559-65. PubMed ID: 3305386 [TBL] [Abstract][Full Text] [Related]
29. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture. Freed BM; Rosano TG; Quick C; Lempert N Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629 [No Abstract] [Full Text] [Related]
30. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells. Morikawa K; Oseko F; Morikawa S Transplantation; 1992 Sep; 54(3):526-31. PubMed ID: 1329279 [TBL] [Abstract][Full Text] [Related]
31. In vitro immunosuppressive effect: a comparative study between deoxymethylspergualin and cyclosporin A, on human lymphocyte responses. Jiang H; Takahara S; Kokado Y; Ishibashi M; Sonoda T J Clin Lab Immunol; 1990 Oct; 33(2):75-81. PubMed ID: 1967069 [TBL] [Abstract][Full Text] [Related]
32. In vitro study of deoxymethylspergualin on functions of lymphocytes and bone marrow cells from healthy volunteers. Kawasaki C; Okamura S; Shimoda K; Nemoto K; Niho Y J Antibiot (Tokyo); 1995 Mar; 48(3):243-7. PubMed ID: 7730159 [TBL] [Abstract][Full Text] [Related]
33. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Kirk AD; Mannon RB; Kleiner DE; Swanson JS; Kampen RL; Cendales LK; Elster EA; Wakefield T; Chamberlain C; Hoffmann SC; Hale DA Transplantation; 2005 Oct; 80(8):1051-9. PubMed ID: 16278585 [TBL] [Abstract][Full Text] [Related]
34. Antigen presentation and HLA-DR expression by FK-506-treated human monocytes. Woo J; Propper DJ; Thomson AW Immunology; 1990 Dec; 71(4):551-5. PubMed ID: 1703987 [TBL] [Abstract][Full Text] [Related]
35. In vitro kinetic study of the immunosuppressive effect of deoxymethylspergualin on human peripheral blood mononuclear cells. Takano Y; Takahara S; Jiang H; Kameoka H; Kokado Y; Moutabarrik A; Ishibashi M; Okuyama A J Clin Lab Immunol; 1991 Apr; 34(4):163-9. PubMed ID: 1668283 [TBL] [Abstract][Full Text] [Related]
36. In vitro analysis of the mode of action of the immuno-suppressive drug 15-deoxyspergualin. Waaga AM; Krzymański M; Ulrichs K; Treumer J; Oko A; Müller-Ruchholtz W Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):155-63. PubMed ID: 8915521 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-2 effect on the inhibition of mixed lymphocyte reaction induced by cyclosporin A. Kim HY; Min WS; Moon H; Bang BK; Lee KS; Kim DJ Korean J Intern Med; 1987 Jul; 2(2):184-9. PubMed ID: 2979004 [TBL] [Abstract][Full Text] [Related]
38. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis. Woo J; Sewell HF; Thomson AW Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113 [No Abstract] [Full Text] [Related]
39. [Immunosuppressive effects of 1 alpha, 25(OH)2D3 on human lymphocytes and monocytes/macrophages. 1. Suppression of PHA-blastogenesis and IL1 and IL2 production]. Iho S; Kura F; Hoshino T; Takahashi T Arerugi; 1985 Apr; 34(4):252-62. PubMed ID: 3876089 [No Abstract] [Full Text] [Related]
40. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation. Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]